Onvida Health is bringing a new era of precision and early detection to lung cancer care in Yuma. The hospital has introduced ...

Summit Therapeutics' ivonescimab outperforms Keytruda in Phase 3 lung cancer trials. Crucial Western market approval depends ...

Final overall survival results show amivantamab plus lazertinib beat out osimertinib for first-line treatment of advanced ...

For Medicaid, you must meet specific income requirements for your state. If you make even $1 too much, you will lose your ...

At Stanford University, Dr. Bryant Lin, a beloved physician and clinical professor, is transforming a personal tragedy into a ...

The 10-week course at Stanford last fall was fully enrolled and packed with students eager to learn from Dr. Lin's unique ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

The Toronto-based company, Altis Labs, claims its AI model is similarly superior at analyzing breast cancer and colorectal ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

A study published last month in Nature highlighted the potential for a new personalized pancreatic cancer vaccine. The trial was tiny, just 16 patients, but it’s ...